Skip to main content
Eligibility
for people ages 18 years and up
Location
at San Francisco, California and other locations
Dates
study started
estimated completion:

Description

Summary

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for acute HF.

Official Title

International Registry to Assess mEdical Practice With lOngitudinal obseRvation for Treatment of Heart Failure

Keywords

Acute Heart Failure Registry Heart failure Hospitalized Global Morbidity Mortality Quality of life AHF

Eligibility

You can join if…

Open to people ages 18 years and up

Patients at least 18 years old, or older for those countries where the adult age is above 18 years of age, hospitalized with a primary diagnosis of acute heart failure.

You CAN'T join if...

1-Concomitant participation in any/a clinical trial with any investigational treatment(for any sponsor).

  1. Use of investigational drugs within 5 half-lives of enrollment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer.

Locations

  • Novartis Investigative Site accepting new patients
    San Diego, California, 92103, United States
  • Novartis Investigative Site accepting new patients
    Vancouver, British Columbia, V6Z 1Y6, Canada
  • Novartis Investigative Site accepting new patients
    Mexico, Distrito Federal, 03100, Mexico
  • Novartis Investigative Site accepting new patients
    Culiacán, Sinaloa SN, 80230, Mexico
  • Novartis Investigative Site accepting new patients
    Edmonton, Alberta, T6G 2B7, Canada
  • Novartis Investigative Site accepting new patients
    Dallas, Texas, 75390, United States
  • Novartis Investigative Site accepting new patients
    Kansas City, Kansas, 66160, United States
  • Novartis Investigative Site accepting new patients
    Aguascalientes, 20230, Mexico
  • Novartis Investigative Site accepting new patients
    San Luis Potosi, 78213, Mexico
  • Novartis Investigative Site accepting new patients
    San Luis Potosi, 78240, Mexico
  • Novartis Investigative Site accepting new patients
    Mexico, Distrito Federal, 06090, Mexico
  • Novartis Investigative Site accepting new patients
    Jackson, Mississippi, 39216, United States
  • Novartis Investigative Site accepting new patients
    Mexico, Distrito Federal, 14080, Mexico
  • Novartis Investigative Site accepting new patients
    Chicago, Illinois, 60611, United States
  • Novartis Investigative Site accepting new patients
    New Orleans, Louisiana, 70121, United States
  • Novartis Investigative Site accepting new patients
    New Orleans, Louisiana, 70112, United States
  • Novartis Investigative Site accepting new patients
    Xalapa, 91020, Mexico
  • Novartis Investigative Site accepting new patients
    Indianapolis, Indiana, 46202, United States
  • Novartis Investigative Site accepting new patients
    Nashville, Tennessee, 37203, United States
  • Novartis Investigative Site accepting new patients
    Xalapa, 91193, Mexico
  • Novartis Investigative Site accepting new patients
    Cinncinnati, Ohio, 45267, United States
  • Novartis Investigative Site accepting new patients
    Detroit, Michigan, 48202, United States
  • Novartis Investigative Site accepting new patients
    Detroit, Michigan, 48201, United States
  • Novartis Investigative Site accepting new patients
    Ottawa, Ontario, K1Y 4W7, Canada
  • Novartis Investigative Site accepting new patients
    Guatemala City, 01011, Guatemala
  • Novartis Investigative Site accepting new patients
    Guatemala, 01011, Guatemala
  • Novartis Investigative Site accepting new patients
    Guatemala, Guatemala
  • Novartis Investigative Site accepting new patients
    New York, New York, 10029, United States
  • Novartis Investigative Site accepting new patients
    Stony Brook, New York, 11794, United States
  • Novartis Investigative Site accepting new patients
    Sainte-Foy, Quebec, G1V 4G5, Canada
  • Novartis Investigative Site accepting new patients
    Halifax, Nova Scotia, B3H 3A7, Canada
  • Novartis Investigative Site accepting new patients
    Panama City, Panamá, Panama
  • Novartis Investigative Site accepting new patients
    Panama, Panamá, Panama
  • Novartis Investigative Site accepting new patients
    San Jose de David, Panamá, Panama
  • Novartis Investigative Site withdrawn
    Panama, Panama
  • Novartis Investigative Site accepting new patients
    Guayaquil, Guayas, Ecuador
  • Novartis Investigative Site accepting new patients
    Quito, Pichincha, 1701, Ecuador
  • Novartis Investigative Site accepting new patients
    Guayaquil, Ecuador
  • Novartis Investigative Site accepting new patients
    Portoviejo, Ecuador
  • Novartis Investigative Site accepting new patients
    Medellin, Antioquia, 0050010, Colombia
  • Novartis Investigative Site accepting new patients
    Medellin, Antioquia, Colombia
  • Novartis Investigative Site accepting new patients
    Barranquilla, Atlantico, Colombia
  • Novartis Investigative Site accepting new patients
    Barranquilla, Atlántico, Colombia
  • Novartis Investigative Site accepting new patients
    Bogotá, Cundinamarca, 110111, Colombia
  • Novartis Investigative Site accepting new patients
    Bucaramanga, Santander, Colombia
  • Novartis Investigative Site accepting new patients
    Armenia, Colombia
  • Novartis Investigative Site accepting new patients
    Bogota, Colombia
  • Novartis Investigative Site accepting new patients
    Bogotá, 00000, Colombia
  • Novartis Investigative Site accepting new patients
    Bogotá, Colombia
  • Novartis Investigative Site accepting new patients
    Cali, Colombia
  • Novartis Investigative Site accepting new patients
    Hønefoss, 3501, Norway
  • Novartis Investigative Site accepting new patients
    Oslo, 370, Norway
  • Novartis Investigative Site accepting new patients
    Skien, NO-3710, Norway
  • Novartis Investigative Site accepting new patients
    Kazan, 420033, Russian Federation
  • Novartis Investigative Site accepting new patients
    Kemerovo, 654005, Russian Federation
  • Novartis Investigative Site accepting new patients
    Krasnodar, 350086, Russian Federation
  • Novartis Investigative Site accepting new patients
    Moscow, 117292, Russian Federation
  • Novartis Investigative Site accepting new patients
    Moscow, 127473, Russian Federation
  • Novartis Investigative Site accepting new patients
    Novosibirsk, 630091, Russian Federation
  • Novartis Investigative Site accepting new patients
    Ryazan, 390026, Russian Federation
  • Novartis Investigative Site accepting new patients
    S-Petersburg, 194354, Russian Federation
  • Novartis Investigative Site accepting new patients
    Saint Petersburg, 197341, Russian Federation
  • Novartis Investigative Site accepting new patients
    Saratov, 410004, Russian Federation
  • Novartis Investigative Site accepting new patients
    Saratov, 410017, Russian Federation
  • Novartis Investigative Site accepting new patients
    St. Petersburg, 191015, Russian Federation
  • Novartis Investigative Site accepting new patients
    St.-Petersburg, 194044, Russian Federation
  • Novartis Investigative Site accepting new patients
    Stavropol, 355030, Russian Federation
  • Novartis Investigative Site accepting new patients
    Tyumen, 625023, Russian Federation
  • Novartis Investigative Site accepting new patients
    Ulyanovsk, 432057, Russian Federation
  • Novartis Investigative Site accepting new patients
    Vladivostok, 690002, Russian Federation
  • Novartis Investigative Site accepting new patients
    Volgograd, 400026, Russian Federation
  • Novartis Investigative Site accepting new patients
    Edgbaston, Birmingham, B15 2WB, United Kingdom
  • Novartis Investigative Site accepting new patients
    Stockton on Tees, Cleveland, TS19 8PE, United Kingdom
  • Novartis Investigative Site accepting new patients
    Bradford, West Yorkshire, BD9 6RJ, United Kingdom
  • Novartis Investigative Site accepting new patients
    Chesterfield, Yorkshire, S44 5BL, United Kingdom
  • Novartis Investigative Site accepting new patients
    Herts, Yorkshire, SG1 4AB, United Kingdom
  • Novartis Investigative Site accepting new patients
    Chesterfield, BS1 3NU, United Kingdom
  • Novartis Investigative Site accepting new patients
    Telford, TF1 6TF, United Kingdom
  • Novartis Investigative Site accepting new patients
    Uxbridge, UB8 3NN, United Kingdom
  • Novartis Investigative Site accepting new patients
    Wakefield, WF1 4DG, United Kingdom
  • Novartis Investigative Site accepting new patients
    York, YO31 8HE, United Kingdom
  • Novartis Investigative Site accepting new patients
    Kitakyushu-city, Fukuoka, 802-8555, Japan
  • Novartis Investigative Site accepting new patients
    Kure, Hiroshima, 737-0023, Japan
  • Novartis Investigative Site accepting new patients
    Sakaide-city, Kagawa, 762-0007, Japan
  • Novartis Investigative Site accepting new patients
    Kita-ku, Okayama, 7000084, Japan
  • Novartis Investigative Site accepting new patients
    Hirakata-City, Osaka, 573-0153, Japan
  • Novartis Investigative Site accepting new patients
    Chiyoda-ku, Tokyo, 101-8643, Japan
  • Novartis Investigative Site accepting new patients
    Nagasaki, 850-8555, Japan
  • Novartis Investigative Site accepting new patients
    Göteborg, 416 85, Sweden
  • Novartis Investigative Site accepting new patients
    Helsingborg, 252 20, Sweden
  • Novartis Investigative Site accepting new patients
    Karlshamn, 37480, Sweden
  • Novartis Investigative Site accepting new patients
    Linkoping, 581 85, Sweden
  • Novartis Investigative Site accepting new patients
    Malmö, 205 20, Sweden
  • Novartis Investigative Site withdrawn
    Norrköping, 60182, Sweden
  • Novartis Investigative Site accepting new patients
    Trollhättan, 46173, Sweden
  • Novartis Investigative Site accepting new patients
    Fortaleza, CE, 60864-190, Brazil
  • Novartis Investigative Site accepting new patients
    Belo Horizonte, MG, 30130-100, Brazil
  • Novartis Investigative Site accepting new patients
    Curitiba, PR, 80010-030, Brazil
  • Novartis Investigative Site accepting new patients
    Rio de Janeiro, RJ, 22280-020, Brazil
  • Novartis Investigative Site accepting new patients
    Campinas, SP, 13060-904, Brazil
  • Novartis Investigative Site accepting new patients
    Tatuí, SP, 18270-170, Brazil
  • Novartis Investigative Site accepting new patients
    Curitiba, Brazil
  • Novartis Investigative Site accepting new patients
    Recife, Brazil
  • Novartis Investigative Site accepting new patients
    Rio De Janeiro, Brazil
  • Novartis Investigative Site accepting new patients
    Sao Jose do Rico Preto, Brazil
  • Novartis Investigative Site accepting new patients
    Amsterdam, 1034CS, Netherlands
  • Novartis Investigative Site accepting new patients
    Groningen, 9713 GZ, Netherlands
  • Novartis Investigative Site accepting new patients
    Leiderdorp, NL-2353 GA, Netherlands
  • Novartis Investigative Site accepting new patients
    Sneek, 8601ZK, Netherlands
  • Novartis Investigative Site accepting new patients
    Venlo, 5912 BL, Netherlands
  • Novartis Investigative Site accepting new patients
    Zwolle, 8025 AB, Netherlands
  • Novartis Investigative Site accepting new patients
    Gyeonggi-do, Bucheon-si, 422-711, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Cheongju-si, Chungcheongbuk-do, 28644, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Wonju, Gangwon-Do, 220-701, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Daejeon, Korea, 301-721, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Busan, 612-896, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Incheon, 403-720, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Pusan, 614-735, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Seoul, 07061, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Seoul, 136-705, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Suwon, 16247, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Taegu, 700 -721, Korea, Republic of
  • Novartis Investigative Site accepting new patients
    Berlin, 13353, Germany
  • Novartis Investigative Site accepting new patients
    Bonn, 53105, Germany
  • Novartis Investigative Site accepting new patients
    Essen, 45356, Germany
  • Novartis Investigative Site accepting new patients
    Freiburg, 79106, Germany
  • Novartis Investigative Site accepting new patients
    Goettingen, 37075, Germany
  • Novartis Investigative Site accepting new patients
    Halle, 06120, Germany
  • Novartis Investigative Site accepting new patients
    Hannover, 30625, Germany
  • Novartis Investigative Site accepting new patients
    Heidelberg, 69120, Germany
  • Novartis Investigative Site accepting new patients
    Homburg, 66421, Germany
  • Novartis Investigative Site accepting new patients
    Lubeck, 23538, Germany
  • Novartis Investigative Site accepting new patients
    Ludwigshafen, 67063, Germany
  • Novartis Investigative Site accepting new patients
    Nürnberg, 90471, Germany
  • Novartis Investigative Site accepting new patients
    Wurzburg, 97078, Germany
  • Novartis Investigative Site accepting new patients
    San Miguel, Santiago, 8900000, Chile
  • Novartis Investigative Site accepting new patients
    Concepcion, Chile
  • Novartis Investigative Site accepting new patients
    Santiago, Piso 1, Chile
  • Novartis Investigative Site accepting new patients
    Santiago, Chile
  • Novartis Investigative Site accepting new patients
    Barcelona, Catalunya, 08035, Spain
  • Novartis Investigative Site accepting new patients
    Tarragona, Catalunya, 43005, Spain
  • Novartis Investigative Site accepting new patients
    Barcelona, Cataluña, 08036, Spain
  • Novartis Investigative Site accepting new patients
    Alicante, Comunidad Valenciana, 03010, Spain
  • Novartis Investigative Site accepting new patients
    Merida, Extremadura, 06800, Spain
  • Novartis Investigative Site accepting new patients
    Mallorca, Islas Baleares, 07198, Spain
  • Novartis Investigative Site accepting new patients
    Las Palmas de Gran Canaria, Las Palmas de G.C, 35020, Spain
  • Novartis Investigative Site accepting new patients
    Majadahonda, Madrid, 28222, Spain
  • Novartis Investigative Site accepting new patients
    Barakaldo, Pais Vasco, 48903, Spain
  • Novartis Investigative Site accepting new patients
    Barcelona, 08041, Spain
  • Novartis Investigative Site accepting new patients
    Cordoba, Spain
  • Novartis Investigative Site accepting new patients
    Leon, 24080, Spain
  • Novartis Investigative Site accepting new patients
    Murcia, 30008, Spain
  • Novartis Investigative Site accepting new patients
    Basel, 4031, Switzerland
  • Novartis Investigative Site accepting new patients
    Bruderholz, 4101, Switzerland
  • Novartis Investigative Site accepting new patients
    Zuerich, 8032, Switzerland
  • Novartis Investigative Site accepting new patients
    Eisenstadt, 7000, Austria
  • Novartis Investigative Site accepting new patients
    Linz, 4021, Austria
  • Novartis Investigative Site accepting new patients
    Moedling, A-2340, Austria
  • Novartis Investigative Site accepting new patients
    Vienna, A-1220, Austria
  • Novartis Investigative Site completed
    Wien, A-1160, Austria
  • Novartis Investigative Site accepting new patients
    Casablanca, Morocco
  • Novartis Investigative Site accepting new patients
    Marrakech, 40 000, Morocco
  • Novartis Investigative Site accepting new patients
    Rabat, 10 000, Morocco
  • Novartis Investigative Site accepting new patients
    Caba, Buenos Aires, C1181ACH, Argentina
  • Novartis Investigative Site accepting new patients
    Caba, Buenos Aires, C1210AAP, Argentina
  • Novartis Investigative Site accepting new patients
    Resistencia, Chaco, H3500CDM, Argentina
  • Novartis Investigative Site accepting new patients
    Buenos Aires, Ciudad de Buenos Aires, 1118, Argentina
  • Novartis Investigative Site accepting new patients
    Coronel Suarez, Ciudad de Buenos Aires, 7540, Argentina
  • Novartis Investigative Site accepting new patients
    Rosario, Santa Fe, 2000, Argentina
  • Novartis Investigative Site accepting new patients
    Rosario, Santa Fe, S2000DSV, Argentina
  • Novartis Investigative Site accepting new patients
    Buenos Aires, C1094AAD, Argentina
  • Novartis Investigative Site accepting new patients
    Buenos Aires, C1426EOB, Argentina
  • Novartis Investigative Site accepting new patients
    Buenos Aires, Argentina
  • Novartis Investigative Site accepting new patients
    Cordoba, X5000JHQ, Argentina
  • Novartis Investigative Site accepting new patients
    Cordoba, X5000, Argentina
  • Novartis Investigative Site accepting new patients
    Corrientes, W3400AFT, Argentina
  • Novartis Investigative Site accepting new patients
    Mendoza, M5500AAJ, Argentina
  • Novartis Investigative Site accepting new patients
    Salta, 4000, Argentina
  • Novartis Investigative Site accepting new patients
    Cluj, Napoca, 400006, Romania
  • Novartis Investigative Site accepting new patients
    Bucharest, 022322, Romania
  • Novartis Investigative Site accepting new patients
    Bucharest, 030 171, Romania
  • Novartis Investigative Site accepting new patients
    Buzau, 120140, Romania
  • Novartis Investigative Site accepting new patients
    Cluj-Napoca, 400006, Romania
  • Novartis Investigative Site accepting new patients
    Focsani, 620034, Romania
  • Novartis Investigative Site accepting new patients
    Lasi, 700075, Romania
  • Novartis Investigative Site withdrawn
    Slobozia, 920013, Romania
  • Novartis Investigative Site accepting new patients
    Timisoara, 300054, Romania
  • Novartis Investigative Site accepting new patients
    Pleven, 5800, Bulgaria
  • Novartis Investigative Site accepting new patients
    Plovdiv, 4002, Bulgaria
  • Novartis Investigative Site accepting new patients
    Sofia, 1202, Bulgaria
  • Novartis Investigative Site accepting new patients
    Sofia, 1527, Bulgaria
  • Novartis Investigative Site accepting new patients
    Sofia, 1606, Bulgaria
  • Novartis Investigative Site accepting new patients
    Varna, 9010, Bulgaria
  • Novartis Investigative Site accepting new patients
    Lin-Kou, 33305, Taiwan
  • Novartis Investigative Site accepting new patients
    Taichung, 40705, Taiwan
  • Novartis Investigative Site accepting new patients
    Tainan, 70421, Taiwan
  • Novartis Investigative Site accepting new patients
    Taipei, 10002, Taiwan
  • Novartis Investigative Site accepting new patients
    Taipei, 110, Taiwan
  • Novartis Investigative Site accepting new patients
    Taipei, 11217, Taiwan
  • Novartis Investigative Site accepting new patients
    Beijing, Beijing, 100044, China
  • Novartis Investigative Site accepting new patients
    Beijing, Beijing, 100191, China
  • Novartis Investigative Site accepting new patients
    Fuzhou, Fujian, China
  • Novartis Investigative Site accepting new patients
    Guangzhou, Guangdong, 510080, China
  • Novartis Investigative Site accepting new patients
    Shijiazhuang, Hebei, 050000, China
  • Novartis Investigative Site accepting new patients
    Wuhan, Hubei, 430074, China
  • Novartis Investigative Site accepting new patients
    Changsha, Hunan, 410005, China
  • Novartis Investigative Site accepting new patients
    Changsha, Hunan, 410011, China
  • Novartis Investigative Site accepting new patients
    Baotou, Inner Mongolia, 014040, China
  • Novartis Investigative Site accepting new patients
    Changchun, Jilin, 130021, China
  • Novartis Investigative Site accepting new patients
    Dalian, Liaoning, 116011, China
  • Novartis Investigative Site accepting new patients
    Beijing, 100022, China
  • Novartis Investigative Site accepting new patients
    Beijing, 100029, China
  • Novartis Investigative Site accepting new patients
    Beijing, 100034, China
  • Novartis Investigative Site accepting new patients
    Beijing, 100053, China
  • Novartis Investigative Site accepting new patients
    Beijing, China
  • Novartis Investigative Site accepting new patients
    Guang Zhou, 510260, China
  • Novartis Investigative Site accepting new patients
    Hangzhou, 310006, China
  • Novartis Investigative Site accepting new patients
    Jinan, 250012, China
  • Novartis Investigative Site accepting new patients
    Luoyang, 471000, China
  • Novartis Investigative Site accepting new patients
    Shanghai, 200080, China
  • Novartis Investigative Site accepting new patients
    Taiyuan, China
  • Novartis Investigative Site accepting new patients
    Urumqi, 830000, China
  • Novartis Investigative Site accepting new patients
    Urumqi, 830054, China
  • Novartis Investigative Site accepting new patients
    Wuhan, 430022, China
  • Novartis Investigative Site accepting new patients
    Xiamen, 361004, China
  • Novartis Investigative Site accepting new patients
    Yangzhou, 225001, China
  • Novartis Investigative Site accepting new patients
    Zhengzhou, 450003, China
  • Novartis Investigative Site accepting new patients
    Zhengzhou, China
  • Novartis Investigative Site accepting new patients
    Monastir, 5000, Tunisia
  • Novartis Investigative Site accepting new patients
    Sousse, 4011, Tunisia
  • Novartis Investigative Site accepting new patients
    Tunis, 1006, Tunisia
  • Novartis Investigative Site accepting new patients
    Tunis, 1007, Tunisia
  • Novartis Investigative Site accepting new patients
    Tunis, 1008, Tunisia
  • Novartis Investigative Site accepting new patients
    Algiers, 16000, Algeria
  • Novartis Investigative Site accepting new patients
    Algiers, 16040, Algeria
  • Novartis Investigative Site accepting new patients
    Algiers, 16206, Algeria
  • Novartis Investigative Site accepting new patients
    Oran, 31000, Algeria
  • Novartis Investigative Site accepting new patients
    Athens, GR, 115 25, Greece
  • Novartis Investigative Site accepting new patients
    Athens, GR, 115 27, Greece
  • Novartis Investigative Site accepting new patients
    Athens, GR, 11527, Greece
  • Novartis Investigative Site accepting new patients
    Thessaloniki, GR, 570 10, Greece
  • Novartis Investigative Site accepting new patients
    Athens, 11526, Greece
  • Novartis Investigative Site accepting new patients
    Athens, 54642, Greece
  • Novartis Investigative Site accepting new patients
    Athens, GR 115 22, Greece
  • Novartis Investigative Site accepting new patients
    Glyfada, 16675, Greece
  • Novartis Investigative Site accepting new patients
    Ioannina, 45100, Greece
  • Novartis Investigative Site accepting new patients
    Piraeus, 18454, Greece
  • Novartis Investigative Site accepting new patients
    Thessaloniki, 54642, Greece
  • Novartis Investigative Site accepting new patients
    Ankara, 06100, Turkey
  • Novartis Investigative Site accepting new patients
    Ankara, 06590, Turkey
  • Novartis Investigative Site accepting new patients
    Bursa, 16059, Turkey
  • Novartis Investigative Site accepting new patients
    Bursa, Turkey
  • Novartis Investigative Site accepting new patients
    Diskapi / Ankara, 06110, Turkey
  • Novartis Investigative Site accepting new patients
    Haydarpasa/Istanbul, 34668, Turkey
  • Novartis Investigative Site accepting new patients
    Istanbul, 34093, Turkey
  • Novartis Investigative Site accepting new patients
    Meselik / Eskisehir, 26480, Turkey
  • Novartis Investigative Site accepting new patients
    Pendik / Istanbul, 34899, Turkey
  • Novartis Investigative Site accepting new patients
    Sivas, 58140, Turkey
  • Novartis Investigative Site accepting new patients
    Baguio City, Baguio, 2600, Philippines
  • Novartis Investigative Site accepting new patients
    Cagayan de Oro City, Cagayan, 9000, Philippines
  • Novartis Investigative Site accepting new patients
    Cebu City, Cebu, 6000, Philippines
  • Novartis Investigative Site accepting new patients
    Davao City, Davao, 8000, Philippines
  • Novartis Investigative Site accepting new patients
    Quezon City, Manila, 1100, Philippines
  • Novartis Investigative Site accepting new patients
    Manila, Metro Manila, 1000, Philippines
  • Novartis Investigative Site accepting new patients
    Angeles City, Pampanga, 2009, Philippines
  • Novartis Investigative Site accepting new patients
    El Chouf, LBN, Lebanon
  • Novartis Investigative Site accepting new patients
    Beirut, 1107 2020, Lebanon
  • Novartis Investigative Site accepting new patients
    Beirut, 6301, Lebanon
  • Novartis Investigative Site accepting new patients
    Beirut, Lebanon
  • Novartis Investigative Site accepting new patients
    Jbeil, Lebanon
  • Novartis Investigative Site accepting new patients
    Saida, 652, Lebanon
  • Novartis Investigative Site accepting new patients
    Jerusalem, 91031, Israel
  • Novartis Investigative Site accepting new patients
    Jerusalem, 91240, Israel
  • Novartis Investigative Site accepting new patients
    Kfar-Saba, 4428164, Israel
  • Novartis Investigative Site accepting new patients
    Nazareth, 16100, Israel
  • Novartis Investigative Site accepting new patients
    Sefad, 13100, Israel
  • Novartis Investigative Site accepting new patients
    Amman, 11121, Jordan
  • Novartis Investigative Site accepting new patients
    Amman, 11196, Jordan
  • Novartis Investigative Site accepting new patients
    Amman, 11942, Jordan
  • Novartis Investigative Site accepting new patients
    Amman, Jordan
  • Novartis Investigative Site accepting new patients
    Irbid, 22110, Jordan
  • Novartis Investigative Site accepting new patients
    Ho Chi Minh City, District 7, Vietnam
  • Novartis Investigative Site accepting new patients
    Ho Chi Minh City, Vietnam
  • Novartis Investigative Site accepting new patients
    Ho Chi Minh, Vietnam
  • Novartis Investigative Site accepting new patients
    Alexandria, 21411, Egypt
  • Novartis Investigative Site accepting new patients
    Cairo, 11566, Egypt
  • Novartis Investigative Site accepting new patients
    Cairo, Egypt
  • Novartis Investigative Site accepting new patients
    El Menia, Upper Egypt, Egypt
  • Novartis Investigative Site accepting new patients
    Suez canal Region, 41111, Egypt
  • Novartis Investigative Site accepting new patients
    Khon Kaen, THA, 40002, Thailand
  • Novartis Investigative Site accepting new patients
    Bangkok, 10310, Thailand
  • Novartis Investigative Site accepting new patients
    Bangkok, 10400, Thailand
  • Novartis Investigative Site accepting new patients
    Chiang Mai, 50200, Thailand
  • Novartis Investigative Site accepting new patients
    Muang, 12120, Thailand
  • Novartis Investigative Site accepting new patients
    Muang, 30000, Thailand
  • Novartis Investigative Site accepting new patients
    Muang, 65000, Thailand
  • Novartis Investigative Site accepting new patients
    Gosford, New South Wales, 2250, Australia
  • Novartis Investigative Site accepting new patients
    Auchenflower, Queensland, 4066, Australia
  • Novartis Investigative Site accepting new patients
    Greenslopes, Queensland, 4120, Australia
  • Novartis Investigative Site accepting new patients
    Bedford Park, SA 5042, Australia
  • Novartis Investigative Site accepting new patients
    Al Ahsa, Saudi Arabia
  • Novartis Investigative Site accepting new patients
    Dammam, 15215, Saudi Arabia
  • Novartis Investigative Site accepting new patients
    Dammam, 31463, Saudi Arabia
  • Novartis Investigative Site accepting new patients
    Khamis Mushayt, 62413, Saudi Arabia
  • Novartis Investigative Site accepting new patients
    Riyadh, 3643, Saudi Arabia
  • Novartis Investigative Site accepting new patients
    New Delhi, Delhi, 110 060, India
  • Novartis Investigative Site accepting new patients
    New Delhi, Delhi, 110017, India
  • Novartis Investigative Site accepting new patients
    New Delhi, Delhi, 110070, India
  • Novartis Investigative Site accepting new patients
    Panaji, Goa, 403001, India
  • Novartis Investigative Site accepting new patients
    Ahmedabad, Gujarat, 380 060, India
  • Novartis Investigative Site accepting new patients
    Vadodara, Gujarat, 390022, India
  • Novartis Investigative Site accepting new patients
    Gurgaon, Haryana, 122001, India
  • Novartis Investigative Site accepting new patients
    Bangalore, Karnataka, 560 069, India
  • Novartis Investigative Site accepting new patients
    Bangalore, Karnataka, 560099, India
  • Novartis Investigative Site accepting new patients
    Manipal, Karnataka, 576104, India
  • Novartis Investigative Site accepting new patients
    Nagpur, Maharashtra, 440008, India
  • Novartis Investigative Site accepting new patients
    Pune, Maharashtra, 411 011, India
  • Novartis Investigative Site accepting new patients
    Pune, Maharashtra, 411011, India
  • Novartis Investigative Site accepting new patients
    Amritsar, Punjab, 143004, India
  • Novartis Investigative Site accepting new patients
    Ludhiana, Punjab, 141001, India
  • Novartis Investigative Site accepting new patients
    Ludhiana, Punjab, 141008, India
  • Novartis Investigative Site accepting new patients
    Chennai, Tamil Nadu, 600037, India
  • Novartis Investigative Site accepting new patients
    Hyderabad, Telangana, 500034, India
  • Novartis Investigative Site accepting new patients
    Hyderabad, Telangana, 500082, India
  • Novartis Investigative Site accepting new patients
    Kolkata, West Bengal, 700 107, India
  • Novartis Investigative Site accepting new patients
    Kolkata, West Bengal, 700099, India
  • Novartis Investigative Site accepting new patients
    India, 560040, India
  • Novartis Investigative Site accepting new patients
    Mumbai, 400053, India
  • Novartis Investigative Site accepting new patients
    New Delhi, 110002, India
  • Novartis Investigative Site accepting new patients
    New Delhi, 110025, India
  • Novartis Investigative Site accepting new patients
    Abu Dhabi, 51900, United Arab Emirates
  • Novartis Investigative Site withdrawn
    Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site accepting new patients
    Al Ain, United Arab Emirates
  • Novartis Investigative Site accepting new patients
    Dubai, 7272, United Arab Emirates
  • Novartis Investigative Site accepting new patients
    Dubai, United Arab Emirates
  • Novartis Investigative Site accepting new patients
    Tangerang, Banten, 15111, Indonesia
  • Novartis Investigative Site accepting new patients
    East Jakarta, DKI Jakarta, 13630, Indonesia
  • Novartis Investigative Site accepting new patients
    South Jakarta, DKI Jakarta, 12430, Indonesia
  • Novartis Investigative Site accepting new patients
    West Jakarta, DKI Jakarta, 11420, Indonesia
  • Novartis Investigative Site accepting new patients
    Surabaya, East Java, 60286, Indonesia
  • Novartis Investigative Site accepting new patients
    Medan, North Sumatera, 20136, Indonesia
  • Novartis Investigative Site accepting new patients
    Padang, Sumatera Barat, 25127, Indonesia
  • Novartis Investigative Site accepting new patients
    Bandung, West Java, 40161, Indonesia
  • Novartis Investigative Site accepting new patients
    Bekasi, West Java, 17144, Indonesia
  • Novartis Investigative Site accepting new patients
    Alor Setar, Kedah, 05460, Malaysia
  • Novartis Investigative Site accepting new patients
    Kota Bahru, Kelantan, 16150, Malaysia
  • Novartis Investigative Site accepting new patients
    Pulau Pinang, Penang, 10990, Malaysia
  • Novartis Investigative Site accepting new patients
    Johor Bahru, 80100, Malaysia
  • Novartis Investigative Site accepting new patients
    Kuala Lumpur, 50586, Malaysia
  • Novartis Investigative Site accepting new patients
    Durban, Kwa-Zulu Natal, 4052, South Africa
  • Novartis Investigative Site accepting new patients
    Bloemfontein, 9301, South Africa
  • Novartis Investigative Site accepting new patients
    Cape Town, 7405, South Africa
  • Novartis Investigative Site accepting new patients
    Cape Town, 7505, South Africa
  • Novartis Investigative Site accepting new patients
    Rivonia, 2128, South Africa

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Novartis Pharmaceuticals
ID
NCT02595814
Study Type
Observational [Patient Registry]
Last Updated
March 1, 2017